コンテンツへスキップ
Merck

主要文書

すべての文書を表示

HIGFBMAG-53K

MILLIPLEX® Human IGF Binding Protein Panel

Configurable Human IGF Binding Protein 7-Plex Panel

ログインで組織・契約価格をご覧ください。

この商品について

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

製品名

MILLIPLEX® Human IGF Binding Protein Panel,

Quality Segment

200

description

Configurable Human IGF Binding Protein 7-Plex Panel

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

technique(s)

multiplexing: suitable

input

plasma
serum
cell culture supernatant(s)

assay range

accuracy: 79%
(IGFBP-5), sensitivity: 0.01 ng/mL
(MinDC+2SD; IGFBP-1), sensitivity: 0.07 ng/mL
(MinDC+2SD; IGFBP-7), sensitivity: 0.12 ng/mL
(MinDC+2SD; IGFBP-6), sensitivity: 0.15 ng/mL
(MinDC+2SD; IGFBP-3), sensitivity: 0.96 ng/mL
(MinDC+2SD; IGFBP-4), sensitivity: 1.09 ng/mL
(MinDC+2SD; IGFBP-2), sensitivity: 9.87 ng/mL
(MinDC+2SD; IGFBP-5), standard curve range: 0.03-25 ng/mL
(IGFBP-1), standard curve range: 0.07-50  ng/mL
( IGFBP-3), standard curve range: 0.07-50 ng/mL
(IGFBP-7), standard curve range: 0.14-100 ng/mL
(IGFBP-6), standard curve range: 0.34-250 ng/mL
(IGFBP-2), standard curve range: 0.69-500 ng/mL
(IGFBP-4), standard curve range: 1.37-1000 ng/mL
(IGFBP-5), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-1), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-2), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-3), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-4), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-5), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-6), inter-assay cv: <15%
intra-assay cv: <10%
(IGFBP-7)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Insulin-like growth factor binding proteins (IGFBPs) regulate the bioavailability and activity of IGFs, playing critical roles in growth, metabolism, aging, and disease progression. This set of biomarkers—IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, IGFBP6, and IGFBP7—provides a comprehensive view of IGF pathway modulation. These analytes are involved in cell proliferation, differentiation, apoptosis, and metabolic regulation, making them valuable for research in cancer, diabetes, aging, and endocrine disorders.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in human serum, plasma, or cell culture supernatants.

Analytes included: IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, IGFBP6, IGFBP7

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:

  • Multiplex magnetic bead-based assay for simultaneous quantification of 7 IGF binding proteins
  • Utilizes Luminex® xMAP® technology for high-throughput and reproducible results
  • Compatible with human serum, plasma, and tissue culture supernatants
  • High sensitivity and wide dynamic range for low-abundance detection
  • Includes all necessary reagents and standards for streamlined workflow
  • Verified for precision, reproducibility, and minimal cross-reactivity
Benefits:

  • Enables comprehensive profiling of IGF binding proteins involved in growth and metabolism
  • Reduces sample volume requirements while maximizing data output
  • Saves time and cost compared to running individual ELISAs
  • Supports research in endocrine signaling, cancer biology, and metabolic regulation
  • Provides reliable, reproducible data for both basic and translational research

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする